Securities code: 003017 stock abbreviation: Zhejiang Dayang Biotech Group Co.Ltd(003017) Announcement No.: 2021-136 Zhejiang Dayang Biotech Group Co.Ltd(003017)
Suggestive announcement on the listing and circulation of issued shares before initial public offering
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. The shares to be released this time are part of the shares issued before the initial public offering. The starting date of the restriction is October 26, 2020, and the commitment period of the restriction is 12 months at the time of issuance;
2. There were 5 shareholders who lifted the initial restricted shares, and the number of shares lifted was 2656000, accounting for 4.43% of the total share capital of the company. The actual number of shares that can be listed and circulated this time is 2656000, accounting for 4.43% of the total share capital; 3. The listing and circulation date of the restricted shares is Friday, December 24, 2021.
1、 Overview of shares issued before IPO
(i) Initial public offering of shares
Approved by the reply on approving Zhejiang Dayang Biotech Group Co.Ltd(003017) initial public offering of shares (zjxk [2020] No. 2415 document) of China Securities Regulatory Commission, Zhejiang Dayang Biotech Group Co.Ltd(003017) (hereinafter referred to as “the company”) issued 15000000 RMB common shares (A shares) for the first time. The notice on listing of Zhejiang Dayang Biotech Group Co.Ltd(003017) RMB common shares was issued by Shenzhen Stock Exchange (SZS [2020] No. 960) agrees that the company will be listed and traded on Shenzhen Stock Exchange on October 26, 2020.
The total share capital of the company before the initial public offering is 45000000 shares and after the initial public offering is 60000000 shares. The number of shares with limited sale conditions after the IPO is 45000000, accounting for 75.00% of the total share capital of the company; The number of shares without sale conditions is 15000000, accounting for 25% of the total share capital of the company.
The total number of shares issued before the initial public offering of the company to lift the restrictions on sales is 2656000, accounting for 4.43% of the total share capital of the company. The number of shares with limited sales conditions that have not been lifted is 17081160, accounting for 28.47% of the total share capital of the company.
（2） Changes in share capital of the company after listing
Since the date of listing, the company has not experienced any change in shares caused by additional share issuance, repurchase cancellation, distribution of stock dividends or conversion of capital reserve into share capital.
2、 Implementation of commitments by shareholders applying for lifting share restrictions
There are 5 shareholders applying for lifting the restrictions on the sale of shares, including Zhoushan Zheke Donggang venture capital partnership (limited partnership), Hangzhou city investment Fuding Investment Management Co., Ltd. – Hangzhou city and equity investment fund partnership (limited partnership), Zhuji Zheke Leying venture capital partnership (limited partnership), Zheng Tiansheng and Xue song.
The specific contents of the commitments made by the shareholders applying for lifting the restrictions on the sale of shares in the announcement on the listing of initial public offerings are as follows:
Within six months before the company’s application for initial public offering was accepted by the CSRC, the newly added shareholders Chenghe investment, Donggang venture capital, Leying venture capital, Xue Song and Zheng Tiansheng promised as follows:
Since the date of completion of the industrial and commercial change registration procedures for the capital increase and shares of the company (i.e. December 24, 2018) within 36 months, the company / I will not transfer or entrust others to manage the company’s shares directly or indirectly held by the company / I before the company’s listing, nor will the company repurchase the company’s shares directly or indirectly held by the company / I before the company’s listing; if the company fails to successfully list or terminate the listing, the company / I will hold the shares Copies are not subject to the above 36 month lock period. At the same time, the company / I will not transfer or entrust others to manage the company’s shares directly or indirectly held by the company / I before the company’s listing, nor will the company repurchase the company’s shares directly or indirectly held by the company / I before the company’s listing within one year from the date when the company’s shares are listed and traded in Shenzhen Stock Exchange.
As of the disclosure date of this announcement, the shareholders applying for lifting the restrictions on the sale of shares have strictly complied with the above commitments and have not violated the above commitments.
The shareholders applying for lifting the restrictions on sales do not occupy the company’s funds for non-profit purposes, and the company has not provided them with illegal guarantees.
The board of directors of the company will supervise relevant shareholders to strictly abide by their commitments when selling shares, and continuously disclose shareholders’ performance of share restriction commitments in periodic reports.
3、 The listing and circulation arrangement of restricted shares is lifted this time
(i) The listing and circulation date of the shares to be deregulated this time is Friday, December 24, 2021. (II) the number of shares to be deregulated this time is 2656000 shares, accounting for 4.43% of the total share capital of the company. The actual number of shares to be listed and circulated this time is 2656000 shares, accounting for 4.43% of the total share capital of the company.
（3） The number of shareholders applying for lifting the restrictions on the sale of shares is 5.
（4） The details of the lifting of restrictions on sale and listing and circulation of shares are as follows:
No. name of shareholder total number of restricted shares actually available for listing
(shares) number of shares outstanding (shares)
Zhoushan Zheke Donggang Chuang
1. Industrial investment partnership 8000000800000
(limited partnership)
Hangzhou Chengtou Fuding investment
Capital Management Co., Ltd
2 – equity of Hangzhou Chenghe 8000000800000
Investment fund partnership
Business (limited partnership)
Zhuji Zhejiang Kele Yingchuang
3. Investment partnership 700000 700000 700000
(limited partnership)
4 Zheng Tiansheng 256000260002560000
5 Xue Song 1000000100000000
4、 Changes in equity institutions before and after the lifting of restrictions on sales
Before this change, the number of changes (shares) after this change
Share type
Proportion of number of shares (shares) (%) increase in number of shares (shares) decrease in number of shares (shares) (%)
1、 2195439336.59-265600019839332.16 tradable shares with limited sales conditions
Including: executive locking shares 22172333.70 — 22172333.70
Restricted shares before IPO 1973716032.90-2656000170816028.47
2、 3804560763.412656000-4070160767.84 tradable shares with unlimited sales conditions
3、 Total number of shares: 600000000 100.002656000265600000000 100.00
5、 Verification opinions of the recommendation institution
After verification, the recommendation institution believes that the listing and circulation of restricted shares meets the requirements of the securities issuance and listing recommendation industry
Measures for the administration of business affairs, listing rules of Shenzhen Stock Exchange, standardized operation of listed companies of Shenzhen Stock Exchange
As a guide (revised in 2020) and other relevant laws, regulations and normative documents; the restricted shares are released
In addition to the restricted sales quantity and listing and circulation time, they all comply with relevant laws, administrative regulations, departmental rules and relevant rules
And shareholder commitments; The shareholders of the company who lifted the restricted shares strictly fulfilled their obligations in the initial public offering
All the commitments made. To sum up, the sponsor has no different opinions on Zhejiang Dayang Biotech Group Co.Ltd(003017) the lifting of the ban on the listing and circulation of restricted shares
Discussion.
6、 Documents for future reference
(i) Application form for listing and circulation of restricted shares; （2） The share structure statement and list of restricted shares; (3) verification opinions of the sponsor; (4) other documents required by Shenzhen Stock Exchange. It is hereby announced.
Zhejiang Dayang Biotech Group Co.Ltd(003017) board of directors December 23, 2021
